Search Results 71-80 of 12819 for Karyotype

  1. Decitabine and Vorinostat Conditioning Followed by CD3-/CD19- NK Cells Infusion for High Risk Myelodysplastic Syndromes - Mayo Clinic

    High risk cytogenetic abnormality as defined by presence of Monosomy 7, complex karytope, or monosomal karyotype; WHO Based Prognostic Scoring System (WPSS): ...

  2. Targeted Therapy Directed by Genetic Testing in Treating Pediatric Patients with Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphomas, or Histiocytic Disorder - Mayo Clinic

    Genetic tests look at the unique genetic material (genes) of patients' tumor cells. Patients with genetic changes or abnormalities (mutations) may benefit more ...

  3. Fetal Cystoscopy for Severe Lower Urinary Tract Obstruction (LUTO) - Mayo Clinic

    Normal karyotype by invasive testing (amniocentesis or CVS). Patients declining invasive testing will be excluded. Family have considered and declined the ...

  4. Mayo Clinic Research Core Facilities - Biomolecular analysis service line

    Mayo Clinic Research Core Facilities: Biomolecular analysis cores focus on genome analysis, proteomics, metabolomics, immunochemistry and cytogenetics.

  5. Longitudinal Characterization and Genetic Analysis of Pediatric-Onset Morphea - Mayo Clinic

    About this study. The purpose of this project is to determine the genetic causes of disease and establish accurate clinical indicators and biomarkers of ...

  6. Genetics of Pediatric Eye Disease - Clinical Trials

    About this study. The purpose of this study is to test the hypothesis that abnormalities of binocular vision underlie the various forms of strabismus by ...

  7. Safety and Efficacy Study of Pracinostat With Azacitadine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia (AML) - Mayo Clinic

    Known AML-associated t(15;17), t(8;21), t(16;16), del(16q), or inv(16) karyotype abnormalities. Presence of a malignant disease within the last 12 months ...

  8. Family History - eMERGE Genome Informed Risk Assessment - Mayo Clinic Research

    Participants provide their family health history for the conditions studied in the eMERGE phase 4 study. To do this, they use the online MeTree tool created ...

  9. Return of Actionable Variants Empirical - Mayo Clinic

    A primary focus of the Mayo group will be on two common actionable genetic disorders–familial hyperlipidemia (FH) and familial colorectal cancer (CRC).

  10. Patient inquiries - Mayo Clinic Research

    Patient inquiries. The High-Dimensional Phenotyping Lab does not schedule or manage patient appointments directly. If you are a patient, learn how you can ...